Herztherapie beim Hund - aktuelle Empfehlung

• Literatur

• 1 Bulmer B, Sisson DD. Theraphy of heart failure. In: Ettinger, Textbook of veterinary internal medicine. 2000: 948-972
• 2 Lombard CW, Jöns O, Bussadori CM. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 2006; Jul-Aug 424: 249-61
• 3 Ettinger SJ et al Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 1998; 213: 1573-1577
• 4 The COVE Study Group: Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. J Vet Intern Med; 1995 9. 243-252
• 5 Kvart C et al Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002; 16: 80
• 6 Atkins CE. Enalapril monotherapy in asymptomatic mitral regurgitation: results of the VetProof trial. Proceedings ACVIM; 2002
• 7 Riordan L, Estrada A. Diuretic Efficacy of Oral Spironolactone when Used in Conjunction with Furosemide in Healthy Adult Greyhounds. Proceedings ACVIM; 2005
• 8 Adin DB et al Intermittent Bolus Injection versus Continuous Infusion of Furosemide in Normal Adult Greyhound Dogs. Proceedings ACVIM; 2003
• 9 Uechi M et al Diuretic Effects of Furosemide Continuous Intravenous Infusion. Proceedings ACVIM; 2006
• 10 The RALES study group: Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol; 1996 Oct15 788. 902-7